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Abstract 
Pregnant rats were administered nicotine (0.6 
mg/kg/day) during different stages of pregnancy. 
Exposure occurred in either the first trimester (days 
1-7), second trimester (days 8-14), third trimester 
(days 15-21), throughout gestation, or not at all 
(nonexposed controls). The effects of prenatal nicotine 
exposure on reproductive, developmental and reflex 
indices were studied. Prenatal nicotine exposure 
resulted in the birth of smaller sized litters for 
first trimester exposed dams, as compared to all other 
groups, except third trimester exposed females. Third 
trimester exposed females gave birth to smaller litters 
than second trimester and control females. Total 
weights of litters from third trimester females were 
lower than second trimester and control females. 
Furthermore, developmental age for eye opening was 
found to be earlier for first trimester animals as 
compared to third trimester or control rats. Also, 
animals exposed throughout gestation showed eye opening 
earlier than controls. Finally, first trimester exposed 
animals acquired the righting reflex sooner than all 
other groups except nonexposed control rats. Control 
animals demonstrated this reflex earlier than second or 
third trimester exposed rats. 
Prenatal nicotine exposure, in this study, did not 
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appear to influence the acquisition or extinction of 
behaviorally conditioned immunosuppression in adult 
rats. The implications of this, regarding nicotine 
dose, the specific area of the immune system examined, 
and the developmental age of the subjects, are 
discussed. 
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The Effects of Prenatal Nicotine Exposure 
on Behaviorally Conditioned Immunosuppression in Rats 
During the past twenty years, a large body of 
empirical research has focused on environmental factors 
which may influence immune system functioning. 
Psychosocial factors such as stress, including peer 
separation, marital discord, and anticipation of cancer 
chemotherapy have all been widely studied. In general, 
stress tends to produce immunosuppressive effects 
across most species. Furthermore, a plethora of 
research has explored the effects of conditioning and 
learning on immune system reactions. Taken together, 
the effects of stress and the data from conditioning 
studies lend strong support to a central nervous system 
(CNS) interaction and mediation of many immune system 
reactions. Furthermore, the field of teratology has not 
only explored prenatal drug effects on nervous system 
development and morphology, but also in utero drug 
effects on immune system development and function. 
As such, the present study set out to explore the 
potential interactions between prenatal drug exposure 
on conditioned effects in the immune system. 
Specifically, since tobacco smoke has long been 
associated with many illnesses, in both the smoker and 
in the offspring of mothers who smoked while pregnant, 
the potential teratogenic effects of nicotine. 
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tobacco's primary psychoactive agent, were examined in 
conjunction with a conditioned immune system reaction. 
The Immune System 
The immune system is a division of the 
reticuloendothelial system (RES), and is responsible 
for the defence of the organism against foreign 
invasion into the internal biological environment 
(Golub, 1977). The primary role of the immune system is 
the detection of "self” from "non-self", and the 
subsequent destruction and elimination of any detected 
"non-self" intrusion. 
The immune system possesses several functional 
organs, some central and others peripheral. The central 
organs of the immune system are the thymus and bone 
marrow, and the peripheral organs are the lymph nodes 
and spleen. The functional cellular units of the immune 
system are the lymphocytes, a specialized type of blood 
cell. Thymus derived lymphocytes or T-cells, mature 
within the thymus, while bone marrow derived 
lymphocytes or B-cells, mature within the bone marrow. 
Also, there are cells within the immune system known as 
macrophages. These are large scavenger cells whose 
primary function is the phagocytosis of larger invading 
antigens. 
All lymphocytes and macrophages are derived from a 
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primordial blood forming cell which originates in the 
bone marrow. These cells are known as pluripotent 
hemopoietic stem cells (Golub, 1977). These stem cells 
in turn develop into either T-cell or B-cell 
precursors. T-cell precursors enter the blood stream 
and migrate to the thymus, where they develop into 
T-lymphocytes. B-cells do not require thymic processing 
for their development into functional cells, and as 
such mature within the bone marrow. 
Immune Response 
Internal exposure to an antigen (invading 
organism) sets into motion an immune response. The 
actual site of entry of the antigen stimulates 
macrophagic cell activity- More central immune 
functioning will involve one, or both, of two distinct 
central immune processes. These are cell mediated 
immunity, and/or humoral immunity. 
Cell mediated immunity primarily involves T-cells, 
and is typically related to tissue rejection (eg; 
kidney transplant) and delayed hypersensitivity (eg; 
tuberculosis skin test). When an antigen makes contact 
with T-cell surface receptors, several chemical 
substances are produced which are cytotoxic in nature. 
Among these are the lymphokines, which are typically 
involved in inflammatory reactions (Golub, 1977), and 
communication with other immune system cells (Jaret, 
Prenatal Nicotine and Immunity 
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1986). 
Humoral immunity is distinct from cell mediated 
immunity in that humoral processes typically involve 
the production of antibody. Antibodies are large 
protein molecules, which possess receptor properties, 
distinct to each specific antigen to which an organism 
is exposed. Initial exposure to antigen, results in a 
pattern of antigen detection and initial antibody 
production referred to as the primary response. 
Subsequent exposure to the same antigen initiates a 
stronger and more robust proliferation of the same 
antibody referred to as the secondary response. 
The biological environment of an organism, 
possesses the means for production of a vast amount of 
molecularly distinct antibodies, each with highly 
specific antigen binding capability. This occurs 
through antigen stimulation of B-cell surface 
receptors, called immunoglobulins. 
There exist within the majority of mammals, five 
distinct classes of immunoglobulins- IgA, IgD, IgE, 
IgG, and IgM- each serving as a B-cell antigen 
receptor. When a specific antigen contacts an 
immunoglobulin receptor, the B-cell transforms into an 
immunoblast. This in turn develops into a plasma cell, 
whose functional purpose is production of antibody. 
This cell will produce the specific antibody which was 
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encoded on the surface immunoglobulin. In essence, the 
antibody is a modified and specific immunoglobulin 
molecule, able to bind exclusively to the invading 
antigen (Golub, 1977). Antibodies act in several ways: 
they combine with and neutralize antigens, as well as 
coating specific antigens thus aiding in their 
destruction by macrophages (Borysenko, 1984). 
The typical immune response involves both cell 
mediated and humoral immune processes. In many cases, 
there exists a symbiotic functioning in which B-cell 
antibody production only occurs in the presence of 
specific T-cells known as "helper” T-cells. There is 
also similar functioning among T-cells. Many specific 
T-cell functions (effector T-cells) can only be 
completed with the assistance of "helper” T-cells 
(Golub, 1977). One antigen which typically initiates a 
B-cell/helper T-cell interaction is sheep red blood 
cells (SRBC). Finally, once invasion by the antigen is 
brought under biological control, immune system 
activity is slowed and terminated through the 
functioning of suppressor T-cells (Jaret, 1986). 
Psychoneuroimmunelogy 
Perhaps a major goal of scientific exploration is 
an attempt to rid humanity of sickness and disease. 
Until recently, it was widely believed that disease 
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states were exclusively biological in nature, and that 
the immune system functioned independently of the 
central nervous system (CNS). However, a large body of 
research now indicates that psychological and 
psychosocial factors can often contribute to immune 
system functions, and initiate the expression and 
progression of diseases traditionally believed to be 
caused by physical factors (Borysenko, 1984). 
During the past fifteen years, new breakthroughs 
in the areas of Biology, Psychology and Immunology have 
given birth to a new and relevant field of study known 
as Psychoneuroimmunology. As indicated by Ader (1980) 
Psychoneuroimmunology is the study of the interactions 
between behavior, the CNS, and the immune system. 
Attempts to demonstrate the interaction between 
psychological processes and immune system functioning 
were first documented by Soviet researchers, some 65 
years ago (Metalnikov and Chorine, 1926; 1928). This 
early research reported that through traditional 
learning paradigms, classical condition of an immune 
response was possible. Specifically, guinea pigs were 
presented with a conditional stimulus (CS), such as a 
scratch or heating of the skin, followed by the 
presentation of the unconditional stimulus (US), an 
intraperitoneal (i.p.) injection of tapioca. Bacillus 
anthrax or a staphylococcus filtrate. When these 
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animals were presented with the CS, 12 to 15 days 
later, they demonstrated an elevation in immune system 
responsiveness in the absence of any antigen, with an 
increase in production of polynucleated peritoneal 
leukocytes (Metalnikov & Chorine, 1926). 
In a later study, Metalnikov and Chorine (1928) 
examined the effects of classical conditioning on 
antibody formation. Rabbits received repeated pairings 
of a CS, similar to that of their previous study, with 
an injection of heat treated Vibrio cholera (US). 
Baseline blood samples were collected three weeks after 
the final CS-US pairing. On the following day some of 
the animals were reexposed to the CS alone and the 
remainder were undisturbed. Those animals reexposed to 
the CS showed rises in antibody titers, while those not 
reexposed showed no such elevations (Metalnikov & 
Chorine, 1928). This effect was further demonstrated in 
the same conditioned animals as long as two months 
after initial conditioning (Metalnikov & Chorine, 
1928). Therefore, early research examining the 
interactions between classical conditioning and immune 
system functioning demonstrated the possible role of 
psychological processes in immune system functioning. 
More recently, Ader and Cohen (1975) demonstrated 
conditioned immunosuppression, using one-trial taste 
aversion learning. In this study, an illness induced 
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taste aversion was produced in rats, by pairing a novel 
saccharin drinking solution, with cyclophosphamide 
(CY), an immunosuppressive, nausea producing drug. 
Three days after this initial conditioning, all animals 
were injected with sheep erythrocytes. Six days 
following inoculation, serum was collected and antibody 
titers were determined for all animals. Placebo treated 
animals (saccharin paired with saline injection) 
produced the highest antibody titers, followed by 
nonconditioned animals (CY injected but not paired with 
saccharin). The lowest antibody titers were produced by 
conditioned animals (Ader & Cohen, 1975). Furthermore, 
when taste aversion was induced using a nausea 
producing, nonimmunosuppressive drug, lithium chloride 
(LiCl), conditioned immunosuppression was not evident 
(Ader St Cohen, 1975). Ader and Cohen (1975) therefore 
conclude that conditioned immunosuppression is not 
necessarily mediated by acute elevations in adrenal 
corticosteroids, resulting from the nonspecific stress 
of taste aversion conditioning; since LiCl, which 
presumably induces equal levels of nonspecific stress 
as CY during conditioning, fails to produce conditioned 
immunosuppression (Ader & Cohen, 1975). The results of 
Ader and Cohen (1975) were further replicated by 
Rogers, Reich, Strom and Carpenter (1976). These 
authors indicate that further research examining the 
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effects of conditioned immunosuppression on separate 
classes of immunoglobulins, would be of interest for 
future study (Rogers et al., 1976). 
Given that antigenic inoculation using SRBC 
involves both T-cell and B-cell interactions, several 
authors have attempted to extend the phenomenon of 
conditioned immunosuppression to thymus independent 
immune reactions. Wayner, Flannery and Singer (1978) 
examined the effects of conditioned immunosuppression 
using SRBC, as well as Brucella abortus (B. abortus), a 
T-cell independent antigen. The authors demonstrate a 
replication of Ader and Cohen's (1975) results using 
SRBC. However, Wayner et al. (1978) indicate that 
conditioned immunosuppression was not found with T-cell 
independent antigenic inoculation. Furthermore, the 
authors report that conditioned immunosuppression 
appears to be dependent upon some aspect of taste 
aversion, since conditioned immunosuppression was found 
to extinguish in conjunction with an extinction of 
taste aversion (Wayner et al., 1978). 
In contrast to Wayner et al. (1978) who employed a 
rat model, Cohen, Ader, Green & Bovbjerg (1979) report 
the successful conditioned immunosuppression of a 
T-cell independent immune response, in the mouse, and 
using the antigen trinitrophenyl (TNP) coupled to the 
thymus independent carrier lipopolysaccharide. As such. 
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although contrasting evidence exists for the ability to 
condition a T-cell independent immune reaction, it is 
possible that reported effects may be both antigen 
specific and species specific. 
Temporal factors have also been addressed 
regarding the CS-US pairing and CS reexposure, in the 
conditioned immunosuppression paradigm. Ader, Cohen and 
Bovbjerg (1982) indicate that reexposure to the CS may 
have long standing effects which alter the threshold of 
activation of cellular immune components, against SRBC. 
Specifically, these authors report that conditioned 
animals reexposed to the CS as long as 15 days after 
initial conditioning, show an attenuated antibody 
response as compared to controls (Ader et al., 1982). 
I 
The extent of conditioning effects on other immune 
system processes are also well documented. Several 
studies have attempted to demonstrate classically 
conditioned enhancement of immune system reactions. 
Jenkins, Chadwick and Nevin (1983) reported a 
conditioned enhancement of antibody production in rats 
exposed to the traditional taste aversion conditioning 
paradigm. These authors exposed rats to a novel 
saccharin drinking solution (CS), followed by an i.p. 
injection of LiCl. Within one hour of this pairing, 
animals were exposed to the US injection of SRBC. Using 
this paradigm, the authors reported enhanced production 
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of antibodies at 13 but not 20 days following CS-US 
pairing (Jenkins et al., 1983). However, methodological 
shortcomings preclude inference of this effect, since 
the authors excluded data from any animals producing 
titers below 4. Furthermore, all titers were performed 
in triplicate, and any sample with a range difference 
in titer of 2 or greater, between the three samples, 
was also excluded from the data. This procedure 
resulted in the exclusion of 15 animals from the 
original sample size of 66, almost one-fourth of the 
total sample, in essence guaranteeing significance. As 
such, these findings should be interpreted with 
caution, since animals not demonstrating elevations in 
antibody production were excluded from any statistical 
analyses. 
However, other studies employing stricter 
methodological considerations have reported conditioned 
elevations in immunological reactivity. Ghanta, 
Hiramoto, Solvason and Spector (1985) demonstrated a 
conditioned increase in natural killer cell (NK) 
activity, when camphor, an olfactory CS, was repeatedly 
paired with poly I:C, a NK inducer. However, in a 
further attempt to demonstrate a conditioned increase 
of NK activity, Dyck, Greenberg and Osachuk (1986) 
demonstrated classically conditioned pharmacological 
tolerance using immunomodulatory drugs. Specifically, 
Prenatal Nicotine and Immunity 
15 
repeated exposure, in mice, to poly I:C, produced a 
conditioned tolerance to the induction of NK activity, 
eight weeks after four treatments per week, with poly 
I:C (Dyck et al., 1986). 
Other research has documented that cell mediated, 
graft-vs~host reactions could be suppressed using 
conditioning procedures (Bovbjerg, Ader & Cohen, 1982). 
Bovbjerg, Ader and Cohen (1984) replicated these 
earlier findings, indicating that conditioned rats 
produced milder graft-vs-host responses, to splenic 
leukocytes injected into the footpad. Furthermore, 
Bovbjerg et al. (1984) reported that this conditioned 
effect is subject to experimental extinction. 
Specifically, animals receiving either 9 or 18 
extinction trials (i-e. exposure to saccharin without 
CY injections) did not differ significantly from 
controls, in graft-vs-host reactions. However, animals 
which received 0 or 4 extinction trials showed milder 
graft-vs-host reactions than did controls (Bovbjerg et 
al., 1984). Interestingly, extinction of conditioned 
immunological effects did not parallel the extinction 
of conditioned taste aversion effects, as was 
previously reported by Wayner et al. (1978). That is, 
while animals receiving 9 or 18 extinction trials 
exhibited extinction of conditioned immunosuppression, 
these animals still demonstrated marked taste aversion 
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to the novel saccharin solution. As such, these authors 
purport that since conditioned immunological responses 
are subject to extinction independently of the 
extinction of conditioned taste aversion, conditioned 
immunosuppression can be dissociated from conditioned 
taste aversion (Bovbjerg et al., 1984). 
Ader and Cohen (1982) have reported that the use 
of conditioned immunosuppression/taste aversion was 
more successful than CY treatment alone, in delaying 
the onset of Autoimmune Systemic Lupus Erythematosus, 
in mice genetically predisposed to this condition. That 
is, mice receiving weekly presentations of saccharin 
and CY showed significantly delayed mortality, as 
compared to mice receiving no such treatment, or CY 
treatment alone (Ader & Cohen, 1982). As such, 
conditioned immunosuppression may have therapeutic 
value in the treatment of certain immunological 
conditions, such as autoimmune disorders- 
Recent evidence indicates that women undergoing 
repeated infusions of cytotoxic agents for the 
treatment of ovarian cancer, experience both increased 
nausea and decreased immune function (conditioned 
immunosuppression), when they anticipate and return to 
the hospital (CS) for subsequent chemotherapy 
treatments (Bovbjerg, Redd, Maier, Holland, Lesko, 
Niedzwiecki, Rubin and Hakes, 1990). Specifically, in 
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vitro proliferation to the T~cell mitogens PHA and Con 
A were lower in blood samples obtained in hospital, as 
compared to those obtained on home visits, several days 
prior to admission for treatment (Bovbjerg et al., 
1990). Although this study examined in vitro immune 
system reactivity, these results are consistent with 
much of the previously mentioned literature on 
conditioned immunosuppression using in vivo animal 
models. 
The implications of such findings may be profound, 
since Gorczysnki, Kennedy and Ciampi (1985) have 
demonstrated that conditioned immunosuppression can 
modify host resistance to tumour growth. Gorczysnki et 
al. (1985) indicate that increased tumour growth and 
mortality was evident in mice exposed to conditioned 
taste aversion/immunosuppression, using CY, following 
transplantation of a syngeneic plasmacytoma. Therefore, 
this finding coupled with those of Bovbjerg et al. 
(1990), may support the theory that, generalized 
environmental cues in the therapeutic setting may come 
to serve as a CS for conditioned immunosuppression, and 
actually work to reduce the overall efficacy of 
chemotherapeutic treatment of neoplastic tumours. 
Hence, early research in psychoneuroimmunelogy 
laid the foundation for exploration into CNS 
interactions and modulations of immune system 
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functioning. Later and ongoing research has attempted 
to apply these findings to the clinical milieu. One 
unexplored area of research in this experimental area 
is the role of drug exposure during pregnancy, and the 
immune system competency of the subsequent offspring. 
Teratology and Immunity 
Much research has been conducted examining 
numerous factors which are involved in immunological 
functioning, such as: psychosocial and biological 
interactions with the immune system. Among these are 
various chemical and pharmacological agents which may 
exert potent teratogenic effects. 
In the field of teratology, perhaps the most 
widely and extensively researched pharmacological agent 
is alcohol. The effects of prenatal alcohol exposure on 
subsequent immune system functioning in offspring has 
been extensively researched. 
A plethora of research has attributed prenatal 
alcohol exposure to immunological dysfunction, both in 
vitro and in vivo, Monjan and Mandell (1980) report 
that in utero exposure to alcohol was found to produce, 
in adulthood, suppression of in vitro mitogen induced 
lymphocyte reactivity. Furthermore, this depressed 
activity was found to be isolated to T-lymphocyte, but 
not B-lymphocyte reactivity. The effect was evident in 
Prenatal Nicotine and Immunity 
19 
tissue cultures taken from rats at 7 and 11 months of 
age, but not 18 months of age, demonstrating a possible 
age dependent relationship (Monjan & Mandell, 1980). 
Recent in vivo studies examining the effects of 
prenatal alcohol exposure on the immune system have 
supported earlier in vitro results. For example, Redei, 
Clark and McGivern (1989) examined immune 
responsiveness as measured by mitogen (Con A) induced 
T-lymphocyte proliferation, in spleen and thymus cells 
of 21 day old rats prenatally exposed to alcohol. The 
authors report a marked decrease in mitogen induced 
lymphocyte proliferation in alcohol exposed animals. 
This effect was found to be 8-fold less in spleen 
cells, and twofold less in thymus cells, for alcohol 
treated rats as compared to nonexposed controls (Redei 
et al., 1989). 
Nair, Kronfol and Schwartz (1990) examined the 
effects of both alcohol and nicotine, in vitro^ on NK, 
antibody-dependent cellular cytotoxic cell (ADCC), and 
lymphokine activated killer cell (LAK) activities. 
Alcohol alone was found to inhibit NK activity, as well 
as depress the lytic capacity of LAK cells. Also, 
nicotine alone was also found to inhibit NK activity. 
When alcohol and nicotine were added together in 
noninhibitory concentrations, a potentiated significant 
suppression of NK was evident (Nair, et al., 1990). 
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These authors speculate that the decreases in immune 
functioning evident in the presence of these common 
recreational substances, may contribute to the 
manifestation and occurrence of the diseases associated 
with smoking and drinking (Nair, et al,, 1990). 
In vivo studies of mothers who smoked during 
pregnancy report significantly lower levels of 
lymphocyte toxins in smokers than nonsmokers (Nymand, 
1974). Furthermore, pregnant smokers were found to have 
a higher incidence of urinary tract infections, as well 
as febrile and non-febrile viral diseases (Nymand, 
1974). It may be possible that such suppressions in 
immune system activity in the presence of nicotine, may 
depress the levels of passive immunity subsequently 
transferred from mother to newborn offspring. 
As such, commonly available drugs, such as 
alcohol, are seen to exert teratogenic effects on 
immune system functioning. Furthermore, Ader (1983) 
indicates that prenatal exposure to many chemicals may 
result in no detectable defects at birth, but may still 
result in behavioral impairments later in life, as they 
emerge. One such commonly used product which has been 
found to exert minimal detectable defects at birth but 
several teratogenic behavioral impairments is tobacco 
smoke; and perhaps more specifically, nicotine (Abel, 
1984). 
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Nicotine 
Pharmacology of Nicotine 
Nicotine, a central nervous system (CNS) 
stimulant, is the primary psychoactive agent in tobacco 
products, and that which attracts people to engage in 
tobacco use. Nicotine is primarily associated with the 
cholinergic system, in both the CNS and the peripheral 
nervous system (PNS). Nicotine readily crosses the 
blood-brain-barrier, as well as the placental barrier, 
thus rendering it a potential teratogen (Abel, 1984). 
However, the pharmacodynamic actions of the drug are 
dependent on dose, target organ and tolerance 
(Benowitz, 1986). 
Nicotine has been found to activate the 
sympathetic nervous system, and in healthy human 
individuals increases blood pressure and heart rate by 
10-20 BPM (Benowitz, 1986). Nicotine has also been 
found to increase levels of circulating norepinephrine 
(NE) and epinephrine (Cryer, Raymond, Santiago & Shah, 
1976). Benowitz (1986) indicates that nicotine is 
associated with electroencephalographic (EEC) 
desynchronization, typical of autonomic stimulation and 
over-arousal. Furthermore, nicotine has been reported 
to increase endocrine levels of the above mentioned 
catecholamines, as well as vasopressin, growth hormone 
(GH), cortisol, adrenocorticotropic hormone (ACTH) and 
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beta-endorphin (Benowitz, 1986). It is this stimulation 
of the endogenous opiate system which may be implicated 
in the positive reinforcing properties of nicotine 
(Karras & Kane, 1980). 
Nicotine and Disease 
The effects of smoking, as related to the 
development of a myriad of health conditions, is widely 
documented. The nicotine in tobacco smoke is a major 
risk factor in coronary and peripheral vascular 
disease, cancer, chronic obstructive pulmonary disease 
(COPD) and peptic ulcer disease. Although these 
conditions have been associated with the additive and 
synergistic effects of the large number of chemical 
constituents in tobacco, nicotine alone has also been 
implicated in the development of many physical diseases 
(Benowitz, 1986). Although nicotine alone is not a 
known carcinogen, it is known to interact with other 
chemicals, thus rendering it a co-carcinogen. Nicotine 
when associated with benzo(a)pyrene, another tobacco 
constituent, has been associated with the development 
of skin cancer in mice (Bock, 1980). 
The potential mediating factor for the increased 
susceptibility to certain disease states associated 
with smoking may be a compromising of immune system 
functioning resulting from exposure to tobacco smoke, 
and perhaps specifically nicotine. Person, Edwards, 
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Lind, Milton and Hersey (1979) report decreased IgG, 
IgA and NK activity in smokers, as compared to 
nonsmokers. Furthermore, similar inhibition of immune 
system function (IgG, IgA and NK activity) was evident 
in melanoma patients, who were smokers that recently 
had the tumour removed, and had not yet commenced 
chemotherapy (Person, et al., 1979). The authors 
speculate that the high incidence of malignancy in 
smokers, may be linked to compromises of certain 
aspects of immune system function important in 
restricting tumour growth (Person, et al., 1979). 
Herscowitz and Cooper (1979) demonstrated that 
postnatal exposure to tobacco smoke in mice produced a 
progressive decline, with age, of splenic plaque 
forming cells (PFC) to SRBC, as compared to nonexposed 
mice. Specifically, when animals were exposed to 
tobacco smoke for various periods of time, beginning 24 
hours postnatally, no differences in their ability to 
produce adequate splenic PFC responses were evident 
(Herscowitz & Cooper, 1979). However, beginning at day 
10, this immunological proficiency began to decline. 
Specifically, smoke exposed mice showed a 30 percent 
reduction at postnatal day 10, 60 percent reduction at 
postnatal day 14, and 90 percent reduction at 10 weeks 
of age as compared to nonexposed mice (Herscowitz & 
Cooper, 1979). As such, this study further corroborates 
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the immunosuppressive nature of tobacco smoke. 
As previously discussed, Nair et al. (1990) 
demonstrated the ability of nicotine alone to exert 
immunosuppressive properties in vitro. This primarily 
included a reduction in NK activity (Nair et al., 
1990). As such, while many studies indicate that 
tobacco smoke, with its vast quantity of chemical 
constituents, produces immunosuppression, Nair et al. 
(1990) have supported that nicotine alone possesses 
potent immunosuppressive properties. 
Nicotine Teratocrenesis 
Nicotine has been reported to increase 
complications associated with pregnancy, as well as 
exert harmful effects on the developing fetus. Maternal 
modulation of nicotine and the levels of nicotine found 
in fetal plasma vary across different species. Abel 
(1984) indicates that nicotine levels in mouse fetal 
tissue tend to be lower than maternal tissue levels. 
However, in the rat, higher plasma levels of nicotine 
are reached in fetal tissue than in maternal plasma. 
Also, both nicotine and its major metabolites have been 
detected in the amniotic fluid of human smokers (Abel, 
1984). Furthermore, Abel (1984) points out that the 
presence of nicotine has been detected in the breast 
milk of women smokers. Thus, the effects of nicotine 
may not only reach the infant in the prenatal 
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environment, but in the early perinatal environment as 
well. 
Smoking during pregnancy has long been associated 
with an increased likelihood of spontaneous abortion, 
lower fetal birth weight, increased perinatal mortality 
such as sudden infant death syndrome (SIDS), some 
physical malformations, and behavioral deficits (Abel, 
1984). 
The effects of smoking during pregnancy and 
prenatal nicotine exposure on subsequent behavioral 
factors in the exposed offspring have been examined. 
Specifically, infants born to mothers who smoked 
performed more poorly on tasks of simple learning such 
as, head turning and sucking (Abel, 1984). Follow-up 
studies of such children indicate impairments in 
reading and mathematics at 11 years of age (Butler & 
Goldstein, 1973). Abel (1984) also reviews that infants 
born to smokers are more likely to display behavioral 
hyperactivity. This finding has subsequently been 
documented in rats prenatally exposed to low doses of 
nicotine (0.3 mg/kg/day), under more controlled 
empirical conditions (De Lellis, 1987). Furthermore, De 
Lellis (1987) reports that rats prenatally exposed to 
nicotine may be differentially affected on classically 
conditioned two-way avoidance learning. 
In light of research which has implicated 
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cigarette smoking with a wide array of diseases in the 
actual smoker, children prenatally exposed to tobacco 
smoke, have also been studied for increased 
susceptibilities to a host of medical conditions- Abel 
(1984) reports that smoking during pregnancy may be a 
mediating factor in SIDS; specifically in women who 
smoked six or more cigarettes per day. It is suggested 
that these infants may exhibit brain stem anomalies 
leading to respiratory difficulties (Abel, 1984), as 
well as impaired fetal lung development (Moessinger, 
1989), resulting from nicotine exposure in utero. 
Children born to smokers have also been found to 
be admitted to hospital more often than children of 
non-smokers- Incidence of admissions due to pneumonia 
and bronchitis is especially elevated in these children 
(Abel, 1984), In one study of 12,734 children, it was 
found that maternal, and not paternal smoking, was 
significantly implicated in hospital admissions due to 
bronchitis and other respiratory tract illnesses, in 
the first five years of life. Furthermore, rates of 
admissions for lower respiratory tract illness were 
found to be as high in children born to mothers who 
stopped smoking immediately after delivery, as in those 
mothers who smoked continuously both during and after 
pregnancy (Taylor & Wadsworth, 1987), This suggests 
that maternal smoking influences the incidence of 
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respiratory illness in children, primarily through a 
teratogenic effect, as opposed to through exposure of 
passive smoke perinatally. Similar findings have been 
reported more recently by Moessinger (1989). While 
Moessinger (1989) indicates that it is possible that 
early postnatal susceptibility to respiratory tract 
infection may be due to impaired fetal lung 
development, Taylor & Wadsworth (1987) indicate that 
this effect may also be mediated by impaired immune 
system development, resultant from exposure to 
cigarette smoke in utero. 
Empirical evidence also exists, linking prenatal 
exposure to smoking with an increased susceptibility to 
cancer. Results from animal studies indicate that in 
utero exposure to tobacco smoke is linked to the 
development of cancer, even though tumours were not 
observed until the animals had reached half of their 
expected lifetime (Nicolov & Chernozemski, 1979). As 
such, it is possible that the teratogenic effects of 
nicotine, in contributing to disease states, may lay 
dormant and not become evident until well into the 
organism's postnatal development. Abel (1984) also 
postulates that the increased susceptibility to cancers 
and other illnesses, in offspring of mothers who smoked 
during pregnancy, may be related to an impairment of 
immunological functioning resulting from in utero 
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exposure to cigarette smoke. 
While many studies have examined the nature of 
smoking during pregnancy, and prenatal nicotine 
exposure on the development of many different disease 
states, no research to date has examined the long term 
effects of this exposure on the adult's subsequent 
immune system functioning. As such, the present study 
will examine the effects of prenatal nicotine exposure 
on immune system functioning in the adult rat. 
Furthermore, given the findings of De Lellis (1987) 
implicating prenatal nicotine exposure in influencing 
classically conditioned two-way avoidance learning, 
possible CNS factors and associated learning mechanisms 
will also be addressed through the use of the 
conditioned immunosuppression paradigm. Finally, by 
examining the effects of nicotine exposure at different 
trimesters of pregnancy, a possible critical period 
effect for immune deficiency may be discerned. 
Method 
Subjects 
Twenty-six experimentally naive, female Satinder's 
Heterogeneous Stock (SHS) rats, weighing approximately 
180-250 grams, were used to breed approximately 150 
experimental animals. This genetic line is a four-way 
cross among other genetically distinct rat lines. These 
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are: Roman high avoidance (RHA), Roman low avoidance 
(RLA), Maudsley reactive (MR), and Maudsley 
non-reactive (MNR) rat lines (Satinder, 1980). 
All females were housed individually, in standard 
laboratory cages with food and water available ad 
libitum. Room temperature was kept at 22°C +/- 1°C, and 
relative humidity was maintained at approximately 50 
percent. All animals were maintained on a 12 hour 
light/dark cycle (lights on at 8:00 a.m.). 
Breeding 
All females were paired with a SHS male rat, for 
the purposes of breeding. Genetic backgrounds of each 
dam/sire pairing were controlled for. That is, care was 
taken to insure that each dam/sire pairing originated 
from unrelated litters, and thus shared minimal genetic 
similarity. As such, this pairing procedure avoided the 
potential confounds of genetic inbreeding. All pairs 
were allowed to mate overnight. Each morning after 
pairing, cages were checked for the presence of a 
vaginal sperm plug. When a plug was detected, this was 
designated as day 0 of pregnancy. On day 0, the male 
was removed and the female was assigned to one of five 
nicotine exposure conditions, matching for body weight. 
Prenatal Nicotine Exposure 
Nicotine (0.6 rog/kg/day) was administered to 
pregnant rats by subcutaneous (s.c.) injection. 
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One-third of the dose (0.2 mg/kg) was given at 9:00 
a.m., and the remaining two-thirds (0.4 mg/kg) was 
administered at 5:00 p.m. Females were exposed to the 
nicotine in one of five possible experimental 
conditions: the first trimester (days 1-7), second 
trimester (days 8-14), third trimester (days 15-21), 
all trimesters (days 1-21), or during none of the 
trimesters (non-injected control group). 
In order to control the potential effects of drug 
exposure on maternal food and fluid consumption, and 
the possible confound of differential nourishment on 
the developing offspring, several possible prospective 
control procedures can be employed. One such procedural 
control is pair-feeding, in which food and water 
consumption of control animals is matched with those of 
experimental animals (Abel, 1981). However, this 
technique may, in itself, introduce new and different 
confounds. For example, pair-fed animals always lag one 
day behind experimental animals on the controlled 
levels of food and fluid intake. This arises because 
the amount of food and water given to control animals 
is directly dependent on the amounts consumed on the 
previous day, by experimental animals. This may have 
serious implications, should drug exposure or the 
necessary lags in paired-feeding, coincide with, or 
fail to coincide with certain critical periods of 
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development (Satinder, 1985). This is of specific 
importance when examining teratogenic effects using a 
rat model, given the brevity of the total length of 
gestation in the rat (i.e. 21 days). 
Satinder (1985) points out that an effective means 
of establishing controls for food and fluid intake, is 
to monitor daily food and fluid consumption of females 
during gestation, as well as body weights, which can 
later be employed as statistical covariates. As such, 
daily body weights, food consumption, and fluid 
consumption were recorded for use as statistical 
controls, by analysis of covariance. 
Postnatal Treatment of Offspring 
On day 20 of pregnancy, pregnant females were 
transferred to stainless steel birthing cages, with 
high grade spruce wood shavings as bedding. The day of 
birth was designated as postnatal day 0. 
In order to isolate prenatal effects from effects 
which may result from postnatal changes in maternal 
care of offspring, due to maternal drug exposure, the 
need to employ cross fostering practices has been 
proposed. However, Joffe (1969) proposes that cross 
fostering may, in itself, introduce new confounds and 
therefore influence behavior in the offspring. Kodama 
(1982) has reported that cross fostering itself, 
altered behavioral development by influencing the 
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appearance certain reflexes, freezing and 
hyperactivity. Also, Ackerman, Hofer and Weiner (1977) 
demonstrated that by 30 days of age, fostered pups 
weighed less, and did not survive food deprivation as 
readily as pups raised by their biological mothers. 
Furthermore, cross fostering implicitly incurs an added 
expense of twice the number of dams, as well as the 
sensitive issue of destruction of the pups born to 
surrogate mothers (Satinder, 1985). 
As such, Satinder (1985) proposes several 
methodological alternatives, which may theoretically 
eliminate the need for cross fostering practises. 
Specifically, possible changes in milk production and 
feeding, and its potential effects on postnatal 
development, can be evaluated by recording body weight 
at birth, at regular intervals after birth, and at 
weaning. Also, differences in the survival rates of 
offspring can also be assessed. Should direct 
observation of maternal behavior provide evidence of 
differential maternal care of offspring, then cross 
fostering practices may be warranted (Satinder, 1985). 
However, previous evidence from this laboratory has 
revealed that prenatal exposure to nicotine does not 
differently influence maternal care of offspring (De 
Lellis, 1987). Hence, in light of these theoretical 
concerns, cross fostering of pups was not used here. 
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Therefore, on day 1 after birth, all dams and pups 
were weighed, litter sizes and total litter weights 
were recorded. All litters were coded such that the 
experimenter was unaware of the prenatal treatment of 
each specific litter. All dams and litters were checked 
daily, but otherwise remained undisturbed, except for 
the purposes of cage cleaning, and testing of 
developmental signs and reflex in the pups. Pups were 
weighed every seventh day until the time of weaning 
(postpartum day 28). From birth until weaning, no 
differences in maternal care of the offspring were 
observed. 
Upon weaning, all experimental animals were housed 
individually, in standard laboratory cages with food 
and water available ad libitum. Room temperature was 
maintained at 22®C +/- l^C, and relative humidity was 
kept at approximately 50 percent. All animals were 
maintained on a 12 hour light/dark cycle (lights on at 
8:00 a.m.). 
Procedure and Design 
This portion of the study (developmental and 
reflex testing) employed a 2 (sex) X 5 (gestational 
period of nicotine exposure) factorial design. 
Approximately 15 male and 15 female offspring from each 
nicotine exposure condition completed each cell of the 
design. In order to control for litter effects (i.e. 
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genetic background), each cell contained animals from a 
minimum of three different litters. That is, each 
experimental cell contained male and/or female animals 
from no less than three different litters, for that 
specific nicotine exposure condition. 
Developmental Signs and Reflexes 
All offspring were tested on several developmental 
signs from birth until approximately day 35 (adapted 
from Jensh, 1981). All litters were coded so that the 
experimenter was unaware of the prenatal treatment of 
each litter. The age of each animal at the time of 
manifestation of each developmental sign and reflex, 
was recorded as per the following criteria (numbers in 
parentheses indicate the day at which assessment of the 
characteristic began): 
Developmental Measures: 
(a) Pinna Detachment; Unfolding of the pinnae of 
both ears into the fully erect position, (day 2) 
(b) Primary Coat of Downy Hair; Initial presence 
of downy hair, (day 8) 
(c) Incisor Eruption: Eruption of upper two 
incisors, (day 6) 
(d) Development of Fur; Initial presence of true 
fur. (day 8) 
(e) Eye Opening; Complete uncovering of the 
membranes over both eyes, (day 10) 
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(f) Sexual Development in Males; Beginning at day 
28, males were examined for overt descent of the 
testes. 
(g) Sexual Development in Females: Each female's 
vaginal orifice was examined for rupture of the vaginal 
membrane. Slight pressure applied to under the base of 
the tail, revealed an open vagina- (day 28) 
Developmental Reflexes 
(a) Righting Reflex: Each pup was placed on its 
dorsal side, on a flat, level surface. The righting 
reflex was considered present if the animal could 
orient itself to the upright position within three 
seconds, on three consecutive trials. The day on which 
the reflex was determined to be present was recorded, 
(day 2) 
(b) Negative Geotaxis: Each animal was required to 
complete a 180° turn, within 30 seconds, after being 
placed on an incline plane of 30°, facing downwards. 
Once again, three consecutive successful trials 
indicated the presence of the reflex. The day on which 
the reflex was determined to be present was recorded, 
(day 10) 
Conditioned Immunosuppression 
At 90 days of age, animals were tested for the 
acquisition of conditioned taste aversion accompanied 
with conditioned immunosuppression. This age was 
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necessary to insure that any maternally (i.e. 
passively) acquired immunoglobulins were no longer 
present in the offspring, and that any antibody 
detected through serological testing, was that produced 
exclusively by the experimental animal (Brambell, 
1958). 
One-third (n=5) of the animals in each prenatal 
nicotine group, were randomly assigned to the 
conditioned group, one-third to a placebo control 
group, and one-third to a non-conditioned control 
group. Therefore, a 2 (male vs. female) X 5 (trimester 
of nicotine exposure) X 3 (behavioral conditioning 
group) design was employed for the conditioned 
immunosuppression phase of the experiment. 
Materials 
In diverging from the traditional design of Ader 
and Cohen (1975) this study used a 5% sucrose solution 
(w/v) for taste aversion conditioning, instead of 
saccharin. Ader and Cohen (1981) have reported 
successful taste aversion conditioning and conditioned 
immunosuppression using sucrose. Furthermore, 
successful conditioning has been reported from this 
laboratory using a 5% sucrose solution as the CS 
(Porter, 1987). The 5% sucrose solution (w/v) served as 
the conditional stimulus (CS) for taste aversion and 
conditioned immunosuppression. 
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Cyclophosphamide monohydrate (CY; Sigma Chemicals, 
St. Louis, MO), in 0.9% saline, injected 
intraperitoneally (75 mg/kg, i.p.), served as the 
unconditional stimulus (UCS) for nonconditioned 
immunosuppression. Seventy-five mg/kg of CY has been 
reported to be enough drug to produce both taste 
aversion and immunosuppression in all (i.e. male and 
female) experimentally tested rats (Ader & Cohen, 
1981). A solution of 1% sheep red blood cells (SRBC; 
Woodlyn Labs, Guelph, Ontario), was washed three times 
with 0.9% phosphate buffered saline, and then suspended 
in 0.9% phosphate buffered saline. This cell suspension 
served as an immunological antigen. Sheep blood cell 
suspensions were prepared regularly, as per specified 
expiry dates, and were stored at 4®C, until needed for 
experimental purposes. 
Baseline 
An initial baseline period lasted 3 days. On day 0 
rats were supplied with food ad libitum, with water 
supplied in two calibrated drinking tubes. All data 
measures were recorded in the morning, at 9:00 a.m. On 
day 1, food and water intake and body weights were 
recorded. On day 2, food and water intake and body 
weights were again recorded. On day 3, all water 
bottles were removed after data were recorded, marking 
the end of the baseline period, and the start of the 




In order to establish a fluid intake regimen, 
animals were restricted to two daily periods of fluid 
intake lasting one hour each; one hour in the morning 
(9:00 a.m. - 10:00 a.m.), and one hour in the afternoon 
(4:00 p.m. - 5:00 p.m.). These two drinking periods 
were maintained for the remainder of the study. The 
preconditioning phase lasted seven days. Body weights, 
food consumption and fluid intake were recorded on each 
day of the preconditioning phase. 
Conditioning Phase 
Conditioned Group. On the first day of 
conditioning (day 0) the two calibrated drinking tubes 
were attached to each cage; both containing a 5% (w/v) 
sucrose solution. These remained in place for the one 
hour morning drinking period. Fluid consumption, food 
intake and body weights were recorded on each day of 
conditioning. Thirty minutes following removal of the 
bottles in the morning drinking period, animals in this 
group were given an injection of 75 mg/kg (i.p.) of CY. 
Ader and Cohen (1975) and subsequent studies have 
employed several subgroups within the conditioned 
group. All conditioned groups received an initial 
saccharin and cyclophosphamide pairing, but varied in 
the subsequent reexposure to the CS. For example, some 
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animals were never reexposed to the CS (CSQ), while 
others were reexposed on one or more occasions (Ader & 
Cohen, 1975). This methodology has been employed in a 
plethora of research examining conditioned 
immunosuppression, which have well documented and 
established the presence of a conditioning effect when 
saccharin or sucrose is paired with CY. Furthermore, 
previous research from this laboratory has successfully 
produced conditioned immunosuppression and taste 
aversion without inclusion of the CSo subgroup (Porter, 
1987). Hence, the present study used a single 
conditioning group, which was initially conditioned and 
reexposed to the CS on only one occasion. 
On days 1 and 2 of the conditioning phase, animals 
were given a free choice of water and 5% sucrose 
solutions, in order to assess overall fluid preference. 
On these days, however, no CY injection was given. On 
day 3 of conditioning, the same protocol as for day 0 
of conditioning was followed, except that on day 3, 
animals were injected i.p. with 2 ml/kg of the 1% SRBC 
suspension, instead of CY. This was done to initiate a 
primary humoral immune response. On days 4 and 5, 
animals were again exposed to a free choice of water 
and 5% sucrose (w/v), as per days 1 and 2, in order to 
further assess fluid preference. No injections were 
given on these days. Therefore, the present study 
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included two fluid preference exposure days following 
each injection day (i.e. CY and SRBC). That is, on the 
two days following initial conditioning and the two 
days following SRBC injection, a free choice fluid 
exposure was used in order to assess overall fluid 
preference. 
Bovbjerg, Ader and Cohen (1984) have demonstrated 
that exposure to 4 extinction trials was insufficient 
to produce extinction of either conditioned 
immunosuppression or conditioned taste aversion. 
Animals in that study which received 9 extinction 
trials showed extinction of immunosuppression but not 
of taste aversion (Bovbjerg et al., 1984). As such, the 
presentation, in the present study, of the CS on the 
four free choice fluid preference trials and one day 3 
nonpaired exposure, would likely not produce extinction 
of taste aversion or immunosuppression. The digressions 
from the Ader and Cohen (1975) paradigm have been used 
previously in this laboratory to successfully condition 
the suppression of a primary humoral response (Porter, 
1987). 
Finally, on days 6-8 (postconditioning phase), 
both drinking tubes were filled with water only. This 
was done in order to minimize the number of extinction 
trials for conditioned immunosuppression and taste 
aversion through further exposure to the sucrose 
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solution. 
In addition to the morning drinking period, all 
animals were also provided with drinking tubes for the 
one hour, afternoon drinking period. However, during 
this period, both tubes contained only water. This 
drinking period was not used for experimental purposes, 
but rather served to minimize relative fluid 
deprivation in the experimental animals. 
On day 9, six days following antigen exposure, 
animals were anesthetized using 0.5 ml/kg of 0.25 mg/ml 
euthanyl (i.p.). Approximately 4-5 mis of blood were 
drawn, via cardiac puncture, using a 20 gauge needle 
attached to a 10 ml tuberculin syringe. All animals 
were then sacrificed by CO2 asphyxiation. 
Nonconditioned Group- All procedures for the 
nonconditioned group were the same as those for the 
conditioned group, except that nonconditioned animals 
received only water in their drinking tubes on 
conditioning (day 0) and antigen exposure days (day 3). 
This group served to isolate the effects of the CY on 
immune responsiveness. 
Some data suggests that primary stimulus 
generalization, in the form of olfactory cues, may 
influence the manifestation of taste aversion by 
decreasing the magnitude of the conditioned response, 
or by decreasing overall fluid intake in control 
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animals (Ader, 1977). As such, nonconditioned animals 
were housed in a separate room from that of both the 
conditioned group and the placebo group, in order to 
eliminate the possibility of a conditioned taste 
aversion to the sucrose solution, through olfactory 
cues. 
Placebo Group. The placebo group was treated with 
the same protocol employed with the conditioned group, 
except that these animals received an i.p. injection of 
0.9% physiological saline solution in place of CY, on 
day 0. The use of this group assisted in isolating the 
effects of the 5% sucrose solution in the acquisition 
of conditioned taste aversion. 
Hematological Analysis 
Blood was allowed to clot overnight at 4°C, and 
was then centrifuged at 4®C and 3000 RPM for 15 
minutes. Serum was removed and stored at -40"C, for 
later testing of antibody concentration, by 
hemagglutinating antibody titer. 
Hemaaalutinatina Antibody Titer 
On the day of serological testing, 150/nl of each 
rat's serum was transferred to a 12 x 75 glass culture 
tube. In order to inactivate complement, these samples 
were placed in a water bath at 57*"C for 30 minutes 
(Ader & Cohen, 1975). 
All antibody titers were done in disposable 
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polystyrene, 96-well, U-shaped, microtitration plates. 
Plates were prepared for an 11 serial, twofold dilution 
of each serum sample, in ratios of: 1:1, 1:2, 1:4, 
through 1:1024. The final well of each sample contained 
only phosphate buffered saline, and served as a 
negative control. Beginning with the second well, 50/il 
of phosphate buffered physiological saline was added to 
each well, using a repeater pipette. 
Final plate preparations were done by adding lOOfjLl 
of the complement inactivated serum, to the first well 
of each row on the microtiter plate. Serial dilutions 
were prepared by taking SOfJtl of undiluted serum (1:1) 
from the first well, and mixing it with the 50jul of 
buffered saline in the second well (1:2). Once mixed, 
50/il of the solution in the second well was then 
removed, and mixed with the buffered saline in the 
third well (1:4). This same process was repeated for 
each of the next wells, until 11 serial dilutions 
(1:1024) were completed. Upon mixing the serum/saline 
mixture in the final well (1:1024), SOjiil of solution 
from the final well was removed and discarded leaving 
50/il of diluted serum. Therefore, each of the first 11 
wells contained SO/ul of the serial twofold serum/saline 
dilution, with the first well containing pure serum, 
and the twelfth well containing only saline. 
Once all the appropriate dilutions were prepared. 
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50/il of 1% SRBC was added to each well of the plate, 
including the final well of saline only. All plates 
were then covered and placed at 21°C, for one hour. At 
that time, each well was visually examined for the 
presence of agglutination. 
Titers for determination of antibody concentration 
were performed in duplicate for each sample (r = +.79). 
The mean of each pair of titer results was recorded for 
each rat. Antibody concentration was recorded as the 
reciprocal of the highest dilution (endpoint of titer) 
producing definite hemagglutination, and expressed as a 
power of the base two (Kwapinski, 1965). The criteria 
for the determination of the endpoint of each 
hemagglutinating antibody titer were adapted from 
Moore, Humphreys and Levett-Moseley (1972). 
Results 
Statistical Analysis 
Antibody concentration was calculated and recorded 
as the reciprocal of the highest dilution producing 
definite hemagglutination and expressed as a power of 
the base two (Kwapinski, 1965). Sucrose solution 
preference was measured as the percentage of total 
morning fluid intake. Developmental signs and reflexes 
were measured in terms of average age of acquisition 
per group. 
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Data obtained from measurements of developmental 
signs and reflexes were statistically analyzed using a 
two-way analysis of variance and for Sex X Prenatal 
Drug Exposure Group (1st, 2nd, 3rd, all trimesters, 
control). Taste aversion data were analyzed using a 2 X 
5 X 3 X (9) repeated measures multivariate analysis of 
variance for Sex X Prenatal Drug Exposure Group X 
Conditioning Group (conditioned, nonconditioned, 
placebo) X (Conditioning Phase) (baseline, 
preconditioning, conditioning day 0, day 1, etc;)- 
Immunological data was analyzed by a 2 X 5 X 3 
factorial analysis of variance for Sex X Prenatal Drug 
Exposure Group X Conditioning Group (conditioned, 
nonconditioned, placebo). When required analysis of 
simple effects, covariance and post hoc analyses were 
also performed. 
Part I; Immunological Measures 
Immunological functioning was measured by 
hemagglutinating antibody titer (Ader & Cohen, 1975; 
Kwapinski, 1965). 
Mean antibody titers for males and females are 
depicted in Figure 1. Results indicate that females 
produced significantly higher titers than did males [F 
(1,156)= 7.594; p < .007]. When body weight for the 
postconditioning period was used for as a covariate, 
sex differences for antibody titers were no longer 
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Figure 1. Mean Antibody Titers and Standard Errors for 
Male and Female Rats During Immunosuppression 
Conditioning. 
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significant [F (1,156)= 3.692; E < .057]. 
Mean antibody titers for trimester group are 
presented in Figure 2. There were no significant 
antibody titer differences found for nicotine trimester 
group. Furthermore, inclusion of relevant covariates 
such as: body weight, sex, food consumption, and fluid 
intake, failed to yield significant trimester group 
differences. 
Mean antibody titers for conditioning groups are 
shown in Figure 3. There were significant differences 
in antibody 
titers for conditioning groups [F (2,156)= 168.376; p 
< .0001]. Furthermore, inclusion of body weight as a 
covariate failed to dramatically influence this effect 
[F (2,156)= 156.138; p <.0001]. The use of sex of 
animal, as a covariate, also failed to account for this 
effect [F (2,156)= 168.528; p < .0001]. 
Scheffe comparisons of cell means revealed that 
placebo animals produced significantly elevated 
antibody titers (i.e. 5.55) compared to those of both 
conditioned and nonconditioned animals. Contrary to 
expectation, antibody titers of nonconditioned animals 
were relatively low (i.e. 1.85), and did not differ 
significantly from those of conditioned animals (i.e. 
1.72; see Figure 3). This is contrary to much of the 
literature on behavioral conditioning of a primary 
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Figure 2. Mean Antibody Titers and Standard Errors for 
Rats Prenatally Exposed to Nicotine (0.6 mg/kg/day) 
During Different Periods of Gestation. 
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Figure 3. Mean Hemagglutinating Antibody Titers and 
Standard Errors, 6 Days after SRBC Inoculation for 
Conditioned, Nonconditioned and Placebo Control 
Animals. 
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humoral immune response, which indicates that 
nonconditioned animals typically produce titers 
significantly higher than those of conditioned animals, 
but still significantly lower than those of placebo 
controls (Ader, 1980; 1981; Ader & Cohen, 1975; Cohen, 
Ader, Green & Bovbjerg, 1979; Porter, 1987; Rogers, 
Reich, Storm & Carpenter, 1976). 
Finally, there were no significant interaction 
effects for sex, trimester of exposure or conditioning 
group on the production of antibody titers. 
Part II: Conditioned Taste Aversion 
In order to assess the extent of conditioned taste 
aversion, animals were given a free choice between 
plain water and a sucrose solution (5% w/v), during the 
one-hour morning drinking period. Sucrose preference 
was determined by calculating percentage of sucrose 
solution consumed relative to the total fluid consumed 
(sucrose + water), for the morning drinking period. 
Since animals were exposed to the free choice paradigm 
on only days 1, 2, 4 and 5 of conditioning, only data 
from these days were used in overall analyses for 
determination of acquisition and maintenance of taste 
aversion. Data from the baseline, preconditioning and 
post conditioning phases were calculated as the mean 
total fluid consumed during those periods. Data from 
conditioning day (Day 0) and antigen day (Day 3) fluid 
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consumption were recorded as total fluid intake for 
those days; since both bottles on each cage contained 
the same drinking solution. In order to assess the 
roles of sex, trimester of nicotine exposure, and 
conditioning on fluid intake and acquisition of taste 
aversion, all data were analyzed using a sex (2) X 
conditioning (3) X trimester group (5) repeated 
measures analysis of variance, for the nine phases of 
taste aversion conditioning (i.e. baseline, 
preconditioning, conditioning day 0, day 1, etc;). When 
appropriate, simple effect, covariance and post hoc 
analyses were performed. 
Means for sucrose preference (i.e. free choice on 
conditioning days 1, 2, 4 and 5) for prenatal nicotine 
exposure group are depicted in Figure 4. Means for 
total fluid intake on days when both bottles contained 
the same solution (i.e. baseline, preconditioning, day 
0, day 3 and post conditioning) are found in Table 1. 
F-ratios for repeated measures analyses are found 
in Table 2. There were no trimester group differences 
found for any of the nine conditioning phases of the 
study (see Figure 4 and Tables 1 and 2). Furthermore, 
no significant interaction effects were revealed (see 
Table 2). 
Analysis by repeated measures MANOVA revealed 
significant sex differences across the 9 conditioning 
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Figure 4. Percentage of Sucrose Solution Consumed on 
Conditioning Days 1, 2, 4 and 5 for Animals Prenatally 
Exposed to Nicotine (0.6 mg/kg/day) During Different 
Periods of Gestation. 
Prenatal Nicotine and Immunity 
53 
Table 1 
Mean Total Fluid Consumption fmls^ for Baseline. 
Preconditioning. Day 0. Day 3. and Post-Conditioning Phases 
for Animals Prenatally Exposed to Nicotine (0.6 mg/kg/day) 
During Different Periods of Gestation 
Baseline Precond Day 0 Day 3 Postcond 
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Table 2 
F~Ratios for Between and Within Subject Effects for Repeated 
Measures Analyses of Taste Aversion Conditioning 
Variation df F Significance 





Sex X Tri 4,156 
Sex X Con 2,156 
Tri X Con 8,156 
Sex X Tri X Con 8,156 
Within Siibjects 
Phase* 8,156 
Sex X Phase 8,156 
Tri X Phase 32,156 
Con X Phase 16,132 
Sex X Tri X Phase 32,156 
Sex X Con X Phase 16,156 
Tri X Con X Phase 64,156 
































Note: * Phase refers to conditioning phase of study (i.e. 
baseline, preconditioning, day 0, day 1, day 2, day 
3, day 4, day 5, postconditioning). 
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Table 3 
Group Means. F-Ratios and Covariates for Sex Differences in Fluid 
Intake During Taste Aversion Conditioning fdavs with both bottles same 
solution! 
Baseline Precond Day 0 Day 3 Postcond 








(Males vs Females) 
Sex F= 20.98* 

























Notes: Significance of £ * ^ < .01. 
Since no significant differences were evident 
for conditioning days 1, 2, 4 and 5 F-Ratio's for 
these days are not included in this table. 
d.f. sex (1,156) 
BW = Body weight for each respective phase 
of conditioning. 
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phases (see Table 2). Simple effects tests indicated 
significant sex differences for total fluid consumed 
during the baseline phase, preconditioning phase, 
conditioning day 0, conditioning day 3, and post- 
conditioning phase of the study, with males consuming 
greater amounts than females. As evident in Table 3, 
all of these significant differences disappeared when 
body weight for each specific experimental phase was 
used as a covariate (see Table 3). 
Analysis with repeated measures MANOVA revealed 
significant conditioning group differences for fluid 
intake for the 9 conditioning phases (see Table 2). 
Analyses for each the conditioning phase are found in 
Table 4. There were no significant conditioning group 
differences found during baseline, preconditioning or 
postconditioning. Significant differences for 
conditioning group were evident on days 0, 1, 2, 3, 4 
and 5 (see Table 4). 
Scheffe comparison of means, for day 0 fluid 
intake, revealed that nonconditioned animals consumed 
significantly less fluid (14.48 mis), than both 
conditioned (15.98 mis) and placebo animals (16.98 
mis). This was expected, since nonconditioned animals 
received water only on day 0, while conditioned and 
placebo animals received the novel and sweet 5% sucrose 
solution. 
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Table 4 
F-Ratios for Conditioning Groups (Conditioned vs 
Nonconditioned vs Placebo^ for Each Conditioning Phase of 




of F  
Baseline 2,156 
Preconditioning 2,156 
Day 0 (CY) 2,156 
Day 1 2,156 
Day 2 2,156 
Day 3 (SRBC) 2,156 
Day 4 2,156 
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Group means for sucrose preference days (days 1, 
2, 4 and 5) for each conditioning group are depicted in 
Figure 5. Scheffe test for comparisons of means for day 
1 indicated that all groups differed significantly from 
each other in sucrose preference, with placebo animals 
consuming 89.9% sucrose solution and nonconditioned and 
conditioned animals consuming 63.2% and 12.4% 
respectively (see Figure 5). Day 2 Scheffe mean 
comparisons revealed that the differences between 
nonconditioned and placebo groups, seen on day 1, were 
no longer present (see Figure 5). 
Conditioning group differences were still evident 
on day 3 with similar Scheffe comparisons to those of 
conditioning day 0. All groups differed significantly 
from each other in total fluid intake. However, unlike 
the data on day 0, conditioned animals consumed little 
of the sucrose solution (2.73 mis), while placebo 
animals consumed 19.7 mis of sucrose solution. As with 
day 1, nonconditioned animals consumed significantly 
less fluid (13.37 mis) than placebo animals, once again 
attributable to the sweetness of the placebo group's 
sucrose solution in contrast to the nonconditioned 
group receiving water only on this day. 
Day 4 mean comparisons revealed a similar pattern 
to that of day 1. As seen in Figure 5, all groups 























Figure 5. Percent Sucrose Solution Consumption on 
Conditioning Days 1, 2, 4, and 5 for Conditioned, 
Nonconditioned and Placebo Control Animals. 
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animals demonstrating the greatest preference for 
sucrose (88.43%), followed by nonconditioned (76.99%), 
and conditioned animals (9.45%). Scheffe comparisons 
for day 5 indicated that placebo and nonconditioned 
animals consumed a significantly greater percentage of 
the sucrose solution (see Figure 5). 
Conditioned Immune Response 
In order to assess the relationship between 
sucrose preference (CS) and the degree of 
immunosuppression (CR), Pearson product moment 
correlations were performed for conditioned animals 
(i.e. sucrose/CY exposed). Positive correlations would 
indicate that animals showing higher preferences for 
sucrose would also have produced the highest antibody 
titers. Conversely, animals demonstrating a low 
preference for the sucrose solution would have produced 
the lowest antibody titers. Therefore, conditioned 
taste aversion would be associated with conditioned 
immunosuppression. Correlation coefficients are 
presented in Table 5. 
Contrary to expectation, results from Table 5 
indicate no significant positive correlations between 
fluid preference and antibody titers for conditioned 
animals. This is suggestive of little relationship 
between taste aversion and immune reactivity, and as 
such conditioned immunosuppression. 
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Table 5 
Pearson Correlation Coefficients for Relationships 
Between Antibody Titer and Experimental Sucrose 
Preference Days, for Conditioned Animals TSucrose/CY 
Exposed "1 
Day 1 Day 2 Day 4 Day 5 
Titer 25 08 11 05 
Percent 






Prenatal Nicotine and Immunity 
62 
Part III: Reproductive Measures 
Reproductive measures for dams in each prenatal 
drug exposure group are shown in Table 6. These data 
include: breeding success (i.e. number paired vs number 
of litters born), litter size at birth and weaning, 
total litter weights at birth and weaning, number of 
still births per group, and ratio of male to female 
pups at birth and weaning. 
These data revealed that average litter size 
differed as a function of nicotine exposure during 
different drug exposure periods [£ (4,199)=10.061; p < 
.001]. Post-hoc Scheffe comparisons of means indicated 
that females exposed in the first trimester had 
significantly smaller litters than females exposed in 
either the second trimester, all trimesters, or 
nonexposed controls. Furthermore, Scheffe comparisons 
indicated that third trimester exposed dams gave birth 
to significantly smaller litters than second trimester 
exposed dams or controls (see Table 6). 
Group data for total litter weights are also found 
in Table 6. Overall litter weights were also found to 
differ as a function of timing of nicotine exposure 
[F (4,199)=5.57; p < .001]. This level was significance 
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Table 6 
Mean Reproductive Measures at Birth and Weaning of Pregnant Rats 
Exposed to Nicotine f0,6 ma/ka/day) Purina Different Periods of 
Gestation 
Pairs Litters Still Males 
births 



















































5.0 10.5 63.8 
5.0 10.5 644.3 
Note; Tri l=Days 1-7 Tri 2=Days 8-14 
BW = body weight 
LS = litter size 
LW = litter weight 
Tri 3=Days 15-21 
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was still present when degrees of freedom for total 
number of litters born (n=21) was used, as opposed to 
total number experimental animals [F (4,21)=5.57 p < 
.001], When litter size was used as a covariate, the 
significance of group differences among average litter 
weights increased [F (4,199)= 10.50; p < .0001]. 
Post-hoc Scheffe analyses revealed that total 
litter weights (at birth), born to females exposed 
during the third trimester, were significantly lower 
than those exposed in the second trimester, and 
controls. These effects were no longer significant with 
total litter weights at weaning [F (4,20)= .230; p < 
.91]. 
There were no significant group differences for 
female body weights on days 0 or 21 of pregnancy, or on 
the first day after birth. Furthermore, no group 
differences were found for percent maternal body weight 
increase, from day of sperm plug detection (pregnancy 
day 0) to postpartum day 1 (see Table 7). 
Part IV: Developmental Signs and Reflexes 
Given the potential effect of prenatal nicotine on 
the growth and development of offspring, and the role 
of body weight in contributing to the manifestation of 
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Table 7 
Body Weights of Pregnant Females Delivering Litters After 

































































































































Table 7 continues... 
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Note; Tri l=Days 1-7 Tri 2=Days 8-14 Tri 3=Days 15-21 
BW = body weight 
+ = Day 0 indicates day on which sperm plug detected. 
* = post birth indicates 24 hours after pups littered. 
++ = percent increase from plug date to BW post birth. 
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many developmental signs and reflexes individual body 
weights were recorded at seven day intervals, until 
weaning at 28 days of age (De Lellis, 1987). 
Body Weights 
Mean body weight measures by sex and trimester of 
nicotine exposure are shown in Table 8. Table 9 lists 
F-ratios for body weight measures at postnatal days 1, 
7, 14, 21, 28, and 90. Given the high degree of 
relationship between litter size and body weight 
(r=+.90 at birth; r=+.67 at weaning), F-ratios for 
analysis of covariance, using litter size at birth and 
total litter weight at birth, as covariates, are also 
shown in Table 9. No significant interaction effects 
were found on any of the developmental signs or 
reflexes, and as such are not reported in these tables. 
Males, at postnatal day 1, were significantly 
heavier than females [F (1,199)=10.09; p < 002]. The 
significant difference between male and female body 
weights, on day 1, was found to increase, when both 
litter size and total litter weight were used as 
covariates [F (1,199)= 14.864; p < .0001]. It should be 
noted however, that the amount of within group 
variability for male and female body weights, on day 1, 
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Table 8 
Mean Body Weights foms^ by Sex. From Birth Until Weaning and 90 
Days of Age, of Rats Prenatally Exposed to Nicotine fO.6 
mg/kg/day) During Different Trimesters of Gestation 
Tri 1 Tri 2 Tri 3 All Ctrl 
Day 1 
Males 6.56 6.11 6.11 
Females 6.24 5.88 5.89 

























































































































Note Tri l=Days 1-7 Tri 2=Days 8-14 Tri 3=Days 15-21 
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Table 9 
F~Ratios. Covariates and p~Values by Aae for Body Weights of 








LS & LW as 
covariate 
Sex X Tri 
sex as 
covariate 
Day 1 Day 7 Day 14 Day 21 Day 28 Day 90 
4.392* 2.734 1.625 3.663* 2.933 3.300 
0.214 4.288* 2.091 0.431 2.195 3.369* 
10.087* 9.852* 14.899* 8.399* 11.94* 986.08* 
14.864* 13.567* 19.824* 10.547* 13.549* N/A 
0.272 0.570 2.409 0.425 0.809 1.440 
0.493 0.470 2.525 0.125 0.404 N/A 
Notes! Significance of F * p < .01. 
d.f. days 1-28 for trimester (4,199), sex (1,199) 
and interaction (4,199). 
d.f. day 90 for trimester (4,156), sex (1,156) and 
interaction (4,156). 
LS = Litter Size 
LW = Total Litter Weight 
N/A = Data not available 
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was very small (S.E.M. = 0.068 and 0.067 respectively), 
and that these small differences in variability may 
account for significant F-ratios (see Tables 8 and 9). 
As shown in Table 8, sex differences in body 
weight were also significant at postnatal day 7, where 
males began to demonstrate the expected heavier weights 
as compared to females [F (1,199)= 9.825; p < .002]. 
Finally, as evident in Table 8, this pattern of males 
heavier than females was found to continue, as 
expected, from day 7 through weaning and until 
postnatal day 90 [F (1,156)=986.07; p < .0001]. 
Body weights differences among trimester groups 
yielded several meaningful results. Specifically, 
significant group differences were noted on postnatal 
days 1, 7 and 21. Although significant group 
differences for body weight on day 1 were found for 
nicotine trimester groups [F (4,199)= 4.392; p < .002], 
the significance disappeared when litter size and total 
litter weight were included as covariates [F (4,199)= 
.214; p < .93]. 
However, as evident in Table 9, using litter size 
and total litter weights as covariates, failed to 
account for trimester differences in body weight on 
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postnatal day 7 [£ (4,199)= 4.288; p < .002]. Scheffe 
test for comparison of means revealed significantly 
elevated weights for first trimester exposed animals, 
as compared to rats exposed in all trimesters. 
Significant differences in body weights were also 
evident on day 21. However, this effect was not 
significant when litter size and litter weight were 
used as covariates (see Table 9). 
Significant body weight differences for trimester 
group were also evident at postnatal day 90, only when 
sex was used as a covariate [F (4,156)= 3.369; p < 
.01]. Due to the large percentage of overall variance 
attributable to sex at this age, Scheffe comparisons of 
means were not possible. As such, cell mean comparisons 
were conducted using a factorial analysis of covariance 
with sex as a covariate. Comparisons of means revealed 
that first trimester exposed animals weighed less than 
did control rats [F (1,63)= 6.789; p < .012; see Table 
8]. 
Developmental Signs 
Group means for developmental signs are shown in 
Table 10. 
Pinna Detachment. There were no significant sex 
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Table 10 
Mean Aae in Days for the Appearance of Developmental Signs 
and Reflexes of Rats Prenatally Exposed to Nicotine fO.6 
mg/kg/day1 Purina Different Trimesters of Gestation 
Tri 1 Tri 2 Tri 3 All Ctrl 
Pinna Detachment 
Males 2.43 2.40 2.45 2.35 2.30 
Females 2.41 2.47 2.50 2.28 2.37 






Males 11.14 11.13 11.27 11.25 11.65 
Females 10.82 10.71 11.13 11.28 11.21 
























Males 14.25 14.47 14.73 14.55 14.87 
Females 14.29 14.47 14.75 14.25 14.84 





Males 7.29 7.20 7.27 7.35 7.13 
Females 7.41 7.12 7.19 7.38 7.11 


























Table 10 continues.... 
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Table 10 (cont.) 
Tri 1 Tri 2 Tri 3 All Ctrl 
Sexual Development 
Males 25.00 25.27 25.00 25.25 25.00 
Females 34.41 35.06 35.06 35.13 34.42 







Males 2.96 5.13 4.77 3.45 3.39 
Females 3.24 5.00 5.25 4.81 3.89 





Males 10.11 10.13 10.00 10.05 10.00 
Females 10.18 10.06 10.06 10.09 10.00 




Note; Tri l=Days 1-7 Tri 2=Days 8-14 Tri 3=Days 15-21 
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differences or trimester group differences for pinna 
detachment. 
Incisor Eruption. There were no significant sex 
differences found for eruption of incisors [F (1,199)= 
5.108; p < .03]. When body weight at day 7 was used as 
a covariate, significant sex differences for incisor 
eruption were found [F (1,199)=10.683; p < .001], with 
the incisors of males developing later than those of 
females. 
Trimester group differences for incisor eruption 
were evident [F (4,199)=3.315; p < .02], with this 
level of significance increasing when litter size and 
body weight at day 7 were used as covariates [F 
(4,199)=3.234; p < .012]. Comparisons of means revealed 
that second trimester animals erupted their incisors 
earlier than animals exposed in all trimesters, or 
controls (see Table 10). 
Primary Coat. No significant differences for sex 
or trimester group were evident for the development of 
a primary coat. 
Eye Opening. There were no significant sex 
differences for eye opening, although significant 
differences were found for trimester group [F (4,199)= 
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6.445; E < .0001]. The significance of this effect 
increased when body weight at postnatal day 14 and 
litter size were used as covariates [F (4,199)=7.398; p 
< .00001]. 
Post hoc Scheffe comparisons of means revealed 
that first trimester animals opened their eyes 
significantly sooner than third trimester and control 
animals. Also, animals exposed in all trimesters 
demonstrated eye opening sooner than controls (see 
Table 10). 
Sexual Development. Due to the differential 
latencies for the manifestation of overt signs of 
sexual development between males and females, sex 
differences for this variable were not addressed. There 
were differences in sexual development for trimester 
group [E (4,199)=3.003; p <.02], with this level of 
significance increasing when body weight on day 28 was 
used as a covariate [F (4,199)= 3.301; p < .01]. This 
level of significance was found to further increase 
when both body weight at postnatal day 28 and litter 
size were used as covariates [F (4,199)= 3.872; p < 
.005]. 
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Developmental Reflexes 
Group means for developmental reflexes of negative 
geotaxis and righting reflex are found in Table 10. 
Negative Geotaxis. There were no significant 
differences for sex or trimester group on measures of 
negative geotaxis. Furthermore, the use of body weights 
at postnatal day 7 and 14, litter size, and/or righting 
reflex as covariates, all failed to change the level of 
significance. 
Righting Reflex. Significant sex differences were 
found for righting reflex [F (1,199)=8.538; p < .004], 
with males demonstrating this reflex sooner than 
females. However, this effect disappeared when litter 
size and body weight at day 7 were used as covariates 
[F (1,199)= 2.678; p < .103]. 
Significant trimester group differences were 
revealed for righting reflex [F (4,199)=15.023; p < 
.0001]. Using litter size and body weight at day 7 as 
covariates did not alter this level of significance [F 
(4,199)= 15.507; p < .0001]. 
Scheffe test for comparisons of means revealed 
that first trimester animals demonstrated the righting 
reflex significantly earlier than second and third 
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trimester rats, as well as animals exposed in all 
trimesters. Also, control animals demonstrated this 
reflex sooner than second and third trimester animals 
(see Table 10). 
Part V; Additional Conditioning Variables 
Body Weights 
Trimester group differences for body weight were 
present during the baseline phase (age 90 days) of the 
study [F (4,156)= 3.30; p < .013]/ with first trimester 
animals having the lowest body weights and control 
animals having the highest body weights (see Tables 8 
and 9). Trimester differences for body weight were not 
evident on any of the other conditioning phases of the 
study (see Table 11). 
As expected, sex differences in body weight were 
evident throughout all the conditioning phases of the 
study (see Table 11). 
Mean body weights for conditioning groups during 
each conditioning phase are depicted in Figure 6. As 
expected, no two groups differed significantly in body 
weight during the baseline, preconditioning or 
conditioning day 0 phases of the study. Body weights 
differed significantly on days 1, 2, 3 and 4 (see 
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Table 11 
F-Ratios for Sex, Trimester Group and Conditioning Group 
Differences in Body Weights Purina Taste Aversion 
Conditioning 
Base Pre Day 0 Day 1 Day 2 
Main Effect 
Sex 986.1* 959.5* 1005.4* 976.8* 963.5* 
Tri 3.300 1.173 1.058 0.991 0.833 
Con 0.261 0.539 1.436 6.510* 7.912* 
Notes; Significance of F * p < .01. 
d.f. for sex (1,156), trimester (4,156) and 
conditioning (2,156). 
no significant interaction effects were found 
Table 11 continues... 
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Table 11 (cont.) 
Day 3 Day 4 Day 5 Post 
Main Effect 
Sex 949.9* 999.9* 923.2* 943.1* 
Tri 1.237 1.029 0.988 0.654 
Con 14.23* 5.757* 4.208 3.309 
Notes; Significance of F * E < -01- 
d.f. for sex (1,156), trimester (4,156) and 
conditioning (2,156). 
no significant interaction effects were found. 






Figure 6. Mean Body Weights for Conditioning Groups 
During Each Phase of Taste Aversion/Conditioned 
Immunosuppression Conditioning. 
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Table 11 and Figure 6). Post hoc analyses revealed that 
both cyclophosphamide (CY) injected groups (conditioned 
and nonconditioned) differed significantly from placebo 
animals, but not from each other. Although group 
differences on conditioning day 5 and during 
postconditioning were no longer significant, 
conditioned and nonconditioned animals still maintained 
body weights lower than those of placebo controls (see 
Figure 6). Theoretically, these phases of the study may 
have been far enough removed temporally from the CY 
induced nausea on day 0, that these animals established 
more typical food consumption patterns at that time. 
Food Consumption 
As expected, sex differences in food consumption 
were evident throughout all phases of conditioning. 
However, when body weight for each given phase was used 
as a covariate for that experimental phase, the 
significant sex difference disappeared, for all phases 
of conditioning. Also, there were no trimester group 
differences found during any of the conditioning 
phases. 
Conditioning group means for food consumption are 
shown in Figure 7. Conditioning effects on food 






Figure 7, Mean Food Consumption for Conditioning Groups 
During Each Phase of Taste Aversion/Conditioned 
Immunosuppression Conditioning- 
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consumption were evident at various phases, and almost 
parallelled those of body weights. That is, no group 
differences were found during baseline, preconditioning 
or conditioning day 0 (see Figures 6 and 7). On day 1, 
CY exposed animals showed significantly reduced food 
intake, and a corresponding decrease in body weight. 
This decrease in food consumption and body weight 
slowly increased to nonsignificant levels by day 5 for 
body weight, and day 4 for food consumption. 
Statistically significant conditioning group 
differences for food consumption were evident on day 1 
[F (2,156)= 73.327; p < .0001], day 2 [F (2,156)= 
69.194; p < .0001], and day 3 [F (2,156)= 15.613; p < 
.0001]. In each case the use of body weight as a 
covariate failed to account for this effect. In each of 
these cases, post hoc analyses revealed a similar 
pattern to that of body weights. That is, conditioned 
and nonconditioned animals differed significantly from 
placebo controls, but not from each other. Although a 
significant difference was not evident on day 4, this 
pattern was still present and corresponded to increases 
in body weights seen on day 5 (see Figures 6 and 7). 




Animals given the novel sucrose solution followed 
by the administration of cyclophosphamide (CY) 
demonstrated a marked aversion to the sucrose solution, 
when subsequently provided the sucrose solution. As 
seen in Figure 5, conditioned animals, provided with a 
free choice between water and sucrose, demonstrated an 
aversion to the sucrose solution, one, two, four, and 
five days following initial conditioning. This was 
evident in that conditioned animals consumed almost 
equal amounts of sucrose solution as placebo animals 
(16.27 mis vs 16.98 mis) on the initial day of 
conditioning (day 0); while on the first day following 
conditioning, conditioned animals consumed only 12% 
sucrose relative to water, as compared to 90% in 
placebo animals. By the fifth day after conditioning, 
the consumption of sucrose by conditioned animals never 
exceeded 15%, as compared to 85% for placebo controls 
(see Figure 5). This aversion to a novel drinking 
solution is similar to findings reported in other 
studies of conditioned taste aversion and conditioned 
immunosuppression (Ader & Cohen, 1975; Ader, et al.. 
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1982; Cohen, et al., 1979; Rogers et al., 1976). 
Furthermore, these results are a replication of those 
previously reported from this laboratory by Porter 
(1987), using the same conditioning paradigm. 
Finally, this study did not demonstrate any marked 
extinction of taste aversion in conditioned animals, 
which showed only a 3% increase in sucrose preference, 
over the four days of free choice fluid exposure (see 
Figure 5). Extinction of conditioned taste aversion may 
have been more evident if conditioned animals were 
provided with more than five extinction trials. 
However, as reported by Bovbjerg et al. (1984), as many 
as 18 extinction trials were insufficient to produce 
any extinction of taste aversion conditioning. Given 
that six days following antigen inoculation has been 
reported to be optimal for antibody production (Ader & 
Cohen, 1981), further extinction trials were not 
included in this study. 
Immunological Responses 
Sex differences. The data from this study present 
several interesting findings concerning the 
immunological responses. As demonstrated by Porter 
(1987), the present study revealed a similar sex 
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difference in antibody titers, in which females 
consistently produced elevated antibody titers as 
compared to males (see Figure 1). However, Porter 
(1987) failed to control for variability resulting from 
sex differences in body weight. The present study 
revealed that sex differences in antibody titers 
covaried with sex differences in body weight. 
Speculation on the possible underlying mechanisms of 
elevated titers in female animals is beyond the scope 
of this study. As such, further research may assist in 
understanding the mediating factors involved in sex 
differences in titers in response to CY exposure. 
Trimester differences- The present study did not 
reveal any effects of prenatal nicotine exposure on the 
production of antibody to sheep red blood cell (anti- 
SRBC). That is, no impairments of antibody production 
were evident in animals prenatally exposed to nicotine 
(see Figure 2). This finding is contrary to several 
authors that indicate that in utero exposure to tobacco 
smoke, and more specifically nicotine, may have 
compromising effects on the immune system (Abel, 1984; 
Moessinger, 1989; Nair, et al., 
Wadsworth, 1987). 
1990; Taylor & 
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Several explanations for a lack of teratogenecity 
of nicotine on immune system functioning, in the 
present study, are plausible. Firstly, interspecies 
differences may play a role in the effects of prenatal 
nicotine on subsequent immune system functioning. That 
is, the aforementioned studies (Abel, 1984; Moessinger, 
1989; Nair, et al., 1990; Taylor & Wadsworth, 1987), 
which report potential teratogenic effects of tobacco 
smoke and/or nicotine on the immune system, all 
employed human subjects or human tissue samples. As 
yet, no specific studies have been reported on the 
development of a rat model of nicotine teratogenecity 
on immune system capabilities. As such, the failure of 
the present study to demonstrate immunological 
deficits, as a function of prenatal nicotine exposure, 
may reflect interspecies differences between humans and 
rats. 
Secondly, previous data from this laboratory has 
demonstrated that the teratogenic dose of nicotine 
employed (0.6 mg/kg/day), is high enough to produce 
functional deficits, but still low enough to spare any 
physical deformities in Satinder's Heterogeneous Stock 
(SHS) animals (De Lellis, 1987). Given the role of the 
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central immunological organs of the immune system 
(thymus gland and bone marrow), for optimal 
immunological reactivity, it is possible that the 
present dose of nicotine was not high enough to affect 
the functional development of these organs, or other 
principle immune system factors; and therefore no 
deleterious effects on immune system capabilities were 
evident. 
Thirdly, the age of the present population of 
subjects may also play a role in these results. That 
is, since these animals were inoculated in adulthood 
(90 days of age), it is possible that the teratogenic 
effects of nicotine on the immune system were no longer 
present. Taylor and Wadsworth (1987) collected human 
data up to five years of age. These authors report 
possible immunological deficits as demonstrated by 
increased numbers of admissions to hospital for 
bronchitis and upper respiratory tract infections, in 
children of mothers who smoked while pregnant. However, 
follow-up data on adult immune system status in these 
individuals is not presented or available. Current 
studies in this lab are investigating a possible dose 
and age effect for the possible teratogenic effects of 
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nicotine on the immune system. 
Fourthly, the use of the hemagglutinating antibody 
titer procedure provides a crude and relative (i.e. 
nonquantitative) measure of immunological activity. As 
such, any sensitive immunological deficits which may 
have been present, in this data, could have been 
overlooked. Therefore, future research employing more 
sophisticated, accurate and quantitative techniques 
such as enzyme linked immunosorbant assay (ELISA) or 
radioimmunoassay, may be warranted. 
Finally, given the vast nature and complexity of 
the immune system, it is possible that some other area 
of immunological activity may have been affected by the 
nicotine dose employed here. However, since the present 
study only measured one aspect of immunological 
functioning, it is possible that the teratogenic 
effects of nicotine on the immune system were 
overlooked. 
Therefore, it is not to say that prenatal nicotine 
exposure has no influence on the functioning of the 
immune system, but rather that further investigation is 
necessary to ascertain if any effects may extend to 
other areas of the immune system and immunological 
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activity. 
Conditioned immunological effects. 
Evidence of conditioned immunological effects were 
difficult to unequivocally determine in the present 
study, due to the observed suppression of titers in 
both conditioned and nonconditioned animals (see Figure 
3). Also, as evident in Table 5, the present study did 
not demonstrate a definitive relationship between taste 
aversion and immunosuppression. Contrary to 
expectation, nonconditioned animals did not produce 
titers significantly greater than those of conditioned 
animals (see Figure 3). Conditioned and nonconditioned 
animals both produced suppressed anti-SRBC titers 
compared to those of placebo controls, and yet not 
significantly different from each other. A plethora of 
studies have demonstrated that nonconditioned animals 
typically produce titers significantly higher than 
those of conditioned animals, but still significantly 
lower than placebo controls (Ader & Cohen, 1975; Ader, 
et al., 1982; Cohen, et al., 1979; Rogers et al., 
1976). Previous research from this laboratory has also 
demonstrated the expected pattern of anti-SRBC antibody 
titers, using the same SHS genetic line of animals, and 
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the same conditioning procedure (Porter, 1987). 
Direct inferences from the present data regarding, 
conditioned immunosuppression, could have been made had 
the inclusion of a comparison group of conditioned 
animals not reexposed to the CS (CSQ) been included. In 
retrospect, replication of this study with the 
inclusion of a group of conditioned animals not 
reexposed to the CS (CSQ), may be warranted. 
However, Wayner et al. (1978) reported that 
nonconditioned animals did not differ significantly 
from cyclophosphamide (CY) exposed conditioned animals, 
in the production of anti-SRBC antibody titers. 
Furthermore, both conditioned and nonconditioned 
animals produced significantly lower titers to those of 
placebo controls (Wayner, et al., 1978). The extensive 
effects of CY on the functioning of the immune system 
has been extensively researched. Kerckhaert, Hofhuis 
and Willers (1977) have reported that a single 
injection of CY can suppress humoral immune functioning 
for up to seven days following administration. This may 
then be followed by a sharp rise in antibody synthesis 
on the eighth or ninth day following CY administration 
(Kerckhaert, 1977). Furthermore, Kerckhaert, et al. 
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(1977) indicate that this effect of CY is dose 
dependent. As such, the almost equal levels of 
immunosuppression seen in both conditioned and 
nonconditioned animals in this study, may reflect the 
extensive immunosuppressive effect of the specific CY 
dose employed. As such, the high dose of CY coupled 
with the short interval between conditioning and 
immunization, may account for the suppressed antibody 
titers seen in conditioned and nonconditioned animals. 
It has been postulated that acute elevations in 
adrenocorticotropic hormone (ACTH), resulting from 
acute and nonspecific stress during taste aversion 
conditioning, may result in the elevation of 
corticosteroids to immunosuppressive levels. As a 
result, subsequent reexposure to the CS may result in a 
conditioned release of these immunosuppressive 
hormones. Ader (1976) has found that taste aversion 
conditioning, using CY, does result in the acute 
release of immunosuppressive levels of corticosteroids. 
Furthermore, it has been reported that the successful 
blockade of CY induced conditioned immunosuppression is 
possible through adrenalectomy (Gorczynski, MacRae & 
Kennedy, 1983). 
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However, elevations in corticosteroid levels with 
taste aversion inducing, nonimmunosuppressive drugs 
have been found to not produce conditioned 
immunosuppression. Ader and Cohen (1975) found that 
lithium chloride (LiCl) was a successful unconditional 
stimulus for taste aversion, but failed to produce any 
conditioned immunosuppressive effects, which were only 
conditioned using CY. Furthermore, Ader and Cohen 
(1975) did not find any elevations in steroid levels 
with LiCl induced taste aversion. Also, later studies 
which reported elevations in corticosterone levels 
using LiCl, also failed to report any conditioned 
immunosuppression (Ader, 1976). 
Taken together, it would appear that conditioned 
immunosuppression may not be mediated by the 
nonspecific release of immunosuppressive corticosteroid 
hormones. However, this is not to say that conditioned 
immunosuppression is not dependent on some other 
underlying physiological phenomenon. Brittain and 
Wiener (1985) postulate that future research may 
examine the role autonomic nerves and other sympathetic 
nervous system mechanisms, in possibly understanding 
the mediating factors in conditioned immunosuppression 




The complete nature of the conditioned 
immunosuppression phenomenon is not fully understood. 
From the present study, the influence of prenatal 
nicotine exposure on either the acquisition or 
extinction of conditioned immunosuppression cannot be 
determined, since unequivocal determination of 
observable conditioned immunosuppression was not 
possible. This however is not to say that exposure to 
nicotine in utero is exempt in exerting potential 
immunomodulatory effects in adulthood- Rather, more 
intensive, controlled and specialized analysis is 
necessary to isolate any specific and subtle 
immunological changes which may result from in utero 
exposure to pharmacological agents. 
In retrospect, several methodological aspects of 
the current paradigm could have been conducted 
differently, to allow more conclusive empirical 
inferences. Replication of the present study using a 
slightly higher nicotine dose (eg. 1.0 mg/kg/day), may 
produce more readily observable immunological effects- 
Furthermore, comparison of prenatal nicotine effects on 
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conditioned immunosuppression across two or three 
separate age groups (eg. 30 days, 60 days, 90 days) may 
provide insight into possible developmental factors. 
Also, reexposure to the CS, and subsequent taste 
preference would be assessed after immunization, 
therefore minimizing the overall number of extinction 
trials. Finally, inclusion of a conditioned group not 
reexposed to the CS (CSo) would be essential in 
establishing a more empirically valid frame of 
reference. 
Hence, the potential effects of prenatal nicotine 
exposure on immunological and conditioned immunological 
effects may be revealed, through the inclusion of these 
stricter methodological considerations. Future research 
may require the testing of individual hypotheses 
through more long term systematic analysis. 
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